Bicara Therapeutics (NasdaqGM:BCAX) Q4 2025 Earnings call March 30, 2026 08:30 AM ET Speaker8Good day, and thank you for standing by. Welcome to the Bicara Therapeutics fourth quarter and full year 2025 earnings call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there'll be a question-and-answer session. To ask a question during the session, you'll need to press star one one on your telephone. You will then hear an automated message advising your hand is raised ...

Connect Biopharma (NasdaqGM:CNTB) Update / briefing March 30, 2026 08:00 AM ET Company ParticipantsBarry Quart - CEO and DirectorDavid Szekeres - PresidentNat Charoensook - VP of Biotechnology Equity ResearchConference Call ParticipantsBrandon Folkes - Managing Director and Senior Healthcare AnalystJulian Harrison - Managing Director and Biotechnology AnalystThomas Flaten - Senior Research AnalystOperatorLadies and gentlemen, thank you for standing by, and welcome to the Connect Biopharma conference call. A ...

CBAK Energy Technology (NasdaqCM:CBAT) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Company ParticipantsArina Tian - IR SpecialistCharles Nemek - ShareholderJiewei Li - CFOZhiguang Hu - CEONone - TranslatorConference Call ParticipantsBrian Lantier - Senior Research AnalystOperatorGood day, ladies and gentlemen. Thank you for standing by, and welcome to CBAK Energy Technology's fourth quarter and full year 2025 earnings conference call. Currently, all participants are in listen-only mode. Later, we will ...

Neumora Therapeutics (NasdaqGS:NMRA) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Company ParticipantsAlyssa Larios - Company RepresentativeBill Aurora - Chief Operating and Development OfficerBrian Abrahams - Global Managing Director and Sector Head of Healthcare ResearchDouglas Tsao - Managing Director of Equity ResearchHelen Rubinstein - VP of Investor Relations and Corporate StrategyJosh Pinto - PresidentMike Milligan - CFONick Brandon - Chief Scientific OfficerPaul Berns - CEOPoorna Kannan - Biotec ...

PDS Biotechnology (NasdaqCM:PDSB) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Company ParticipantsFrank Bedu-Addo - CEOKirk Shepard - CMOLars Boesgaard - CFOMayank Mamtani - Senior Managing DirectorMike Moyer - Managing DirectorConference Call ParticipantsJosh Korsen - AnalystOperatorGreetings, and welcome to the PDS Biotechnology Q4 2025 Earnings Call. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation. If anyone should require ope ...

CBAK Energy Technology (NasdaqCM:CBAT) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Company ParticipantsArina Tian - IR SpecialistCharles Nemec - ShareholderJiewei Li - CFO and Company SecretaryZhiguang Hu - CEONone - TranslatorConference Call ParticipantsBrian Lantier - Senior Research AnalystOperatorGood day, ladies, and gentlemen. Thank you for standing by, and welcome to CBAK Energy Technology's fourth quarter and full year 2025 earnings conference call. Currently, all participants are in listen-onl ...

PDS Biotechnology (NasdaqCM:PDSB) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Company ParticipantsFrank Bedu-Addo - CEOKirk Shepard - CMOLars Boesgaard - CFOMayank Mamtani - Senior Managing DirectorMike Moyer - Managing DirectorConference Call ParticipantsJosh Korsen - AnalystOperatorGreetings, and welcome to the PDS Biotechnology fourth quarter 2025 earnings call. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation. If anyone should ...

Neumora Therapeutics (NasdaqGS:NMRA) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Company ParticipantsAlyssa Larios - Company RepresentativeBill Aurora - Chief Operating and Development OfficerBrian Abrahams - Global Managing Director and Sector Head of Healthcare ResearchDouglas Tsao - Managing Director of Equity ResearchHelen Rubinstein - VP of Investor Relations and Corporate StrategyJosh Pinto - PresidentJulian Pino - Biotechnology Equity Research Senior AssociateMike Milligan - CFONick Brandon - Ch ...

Viridian Therapeutics (NasdaqCM:VRDN) Update / briefing March 30, 2026 08:00 AM ET Company ParticipantsAlex Thompson - Research Managing Director of Biotech Equity ResearchFaisal Khurshid - Managing Director of Equity ResearchGavin Clark-Gartner - Managing Director of Biotechnology Equity ResearchGreg Rossino - Senior Director of Investor RelationsGregory Renza - Managing DirectorJason Butler - Managing DirectorLaura Chico - Managing DirectorLisa Walter - VPRadhika Tripuraneni - Chief Medical OfficerShan Wu ...

CBAK Energy Technology (NasdaqCM:CBAT) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Speaker4Good day, ladies and gentlemen. Thank you for standing by, and welcome to CBAK Energy Technology's fourth quarter and full year 2025 earnings conference call. Currently, all participants are in listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. As a reminder, we are recording today's call. If you have any objections, you may disconnect at this time. ...